Watchlist Manager

Watchlist

Price: 1 846 KRW 2.44% Market Closed

Market Cap: ₩62.7B

M	Myungmoon Pharm Co Ltd KRX:017180	KR
	Edreams Odigeo SA MAD:EDR	ES
K	Kone Oyj OMXH:KNEBV	FI
	United Bancorp Inc NASDAQ:UBCP	US
	APA Corp (US) NASDAQ:APA	US
	TraWell Co SpA MIL:TWL	IT
	Inly Media Co Ltd SSE:603598	CN
D	Dagi Yatirim Holding AS IST:DAGHL.E	TR
F	Fast Accounting Co Ltd TSE:5588	JP
	Vistar Holdings Ltd HKEX:8535	HK
J	Jaya Tiasa Holdings Bhd KLSE:JTIASA	MY
Z	Zhejiang China Light & Textile Industrial City Group Co Ltd SSE:600790	CN
B	Bright Outdoor Media Ltd BSE:543831	IN
	Minmetals Development Co Ltd SSE:600058	CN

Balance Sheet

Currency: KRW

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	184	369	328	490	618	1 145	318	7 707	4 456	4 059	3 189	2 868	3 091	4 611	2 498	17 626	1 397	623	572	4 553	6 813	4 858	7 962	4 392
Cash	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12
Cash Equivalents	184	369	328	490	618	1 145	318	7 707	4 456	4 059	3 189	2 868	3 091	4 611	2 498	17 626	1 397	623	572	4 553	6 813	4 858	7 962	4 380
Short-Term Investments	1 036	542	130	1 410	2 695	3 463	2 252	496	890	9 896	4 411	7 729	8 638	1 393	3 317	10	280	4 444	4 237	2 765	284	407	103	165
Total Receivables	5 723	6 919	10 911	10 890	16 734	20 569	28 652	39 657	47 380	78 270	85 761	70 984	73 568	70 528	66 570	69 043	73 302	74 574	63 698	35 659	30 345	34 700	38 928	42 190
Accounts Receivables	5 589	6 796	10 671	10 376	16 100	19 454	26 697	37 549	45 133	76 579	83 946	69 295	71 647	68 828	63 550	65 537	68 758	70 190	59 136	29 898	27 585	29 598	33 649	38 107
Other Receivables	134	123	240	514	634	1 115	1 955	2 108	2 247	1 691	1 815	1 689	1 921	1 700	3 020	3 506	4 544	4 384	4 562	5 761	2 759	5 102	5 279	4 083
Inventory	1 682	3 022	3 498	4 050	4 417	4 752	6 875	8 932	12 211	14 559	16 821	18 106	16 476	17 498	18 390	19 117	20 918	20 447	26 079	30 246	26 032	25 660	30 280	32 685
Other Current Assets	130	121	15	14	924	658	685	497	853	446	386	463	766	7 883	6 149	6 057	10 656	6 883	6 156	7 354	3 993	5 083	4 164	897
Total Current Assets	8 755	10 973	14 883	16 854	25 388	30 588	38 782	57 290	65 791	107 230	110 568	100 150	102 539	101 915	96 925	111 854	106 554	106 971	100 742	80 577	67 466	70 707	81 436	80 329
PP&E Net	3 054	2 867	3 269	7 708	8 191	9 376	13 226	29 498	65 562	74 935	75 113	75 303	77 867	78 001	98 089	105 796	125 420	131 418	154 202	149 944	142 861	141 777	140 196	161 994
PP&E Gross	3 054	2 867	3 269	7 708	8 191	9 376	13 226	29 498	65 562	74 935	75 113	75 303	77 867	78 001	98 089	105 796	125 420	131 418	154 202	149 944	142 861	141 777	140 196	161 994
Accumulated Depreciation	6 114	6 444	6 784	7 483	8 511	9 654	10 937	12 934	15 838	11 463	12 147	14 184	16 143	17 904	19 313	21 158	22 843	24 093	26 497	29 340	29 643	32 144	36 533	40 529
Intangible Assets	69	63	56	50	68	58	495	971	768	5 532	5 480	4 470	4 367	2 799	2 846	1 336	1 278	1 380	570	330	247	318	267	529
Goodwill	0	160	120	80	40	15	23	131	5 638	5 595	5 793	5 933	5 933	5 943	444	434	434	434	434	434	0	0	0	0
Note Receivable	1	1	0	0	0	0	0	60	60	0	60	0	0	0	0	0	0	0	0	56	0	0	0	309
Long-Term Investments	236	163	489	1 933	2 406	3 195	6 463	9 106	14 437	3 163	4 806	2 170	1 309	1 577	594	1 075	899	1 905	3 704	6 938	7 994	9 151	6 190	8 016
Other Long-Term Assets	447	474	762	812	285	271	379	401	1 594	1 035	683	310	396	427	519	580	492	957	4 790	4 745	4 694	8 496	8 459	6 812
Other Assets	0	160	120	80	40	15	23	131	5 638	5 595	5 793	5 933	5 933	5 943	444	434	434	434	434	434	0	0	0	0
Total Assets	12 562 N/A	14 701 +17%	19 579 +33%	27 438 +40%	36 378 +33%	43 502 +20%	59 369 +36%	97 457 +64%	153 850 +58%	197 490 +28%	202 504 +3%	188 337 -7%	192 410 +2%	190 661 -1%	199 417 +5%	221 075 +11%	235 077 +6%	243 066 +3%	264 442 +9%	243 025 -8%	223 263 -8%	230 450 +3%	236 549 +3%	257 988 +9%
Liabilities
Accounts Payable	994	2 491	2 788	2 218	3 209	3 714	5 719	5 812	7 296	9 426	12 090	10 196	8 951	11 057	10 351	13 365	14 944	15 481	16 683	15 905	13 633	15 677	16 746	17 382
Accrued Liabilities	263	213	329	432	882	1 238	963	3 085	3 374	6 269	5 301	4 936	5 421	4 971	5 897	6 306	6 468	8 007	8 285	9 751	12 574	12 970	17 336	17 971
Short-Term Debt	5 144	5 535	0	1 100	1 900	5 260	10 354	3 000	27 760	63 743	66 324	66 137	70 840	84 270	89 403	83 049	84 019	90 077	89 334	82 397	75 657	73 503	74 607	42 114
Current Portion of Long-Term Debt	140	120	0	180	4 362	925	1 689	2 080	6 560	2 661	1 225	975	20 253	1 180	1 553	449	93	1 238	3 530	8 695	2 518	2 350	2 830	10 063
Other Current Liabilities	1 503	548	1 169	840	3 861	3 139	4 301	5 278	4 449	4 762	5 482	5 389	6 014	5 680	9 901	7 338	9 012	8 552	15 551	8 572	8 706	6 321	4 852	5 130
Total Current Liabilities	8 044	8 906	4 286	4 770	14 213	14 275	23 027	19 254	49 439	86 861	90 422	87 635	111 478	107 158	117 106	110 506	114 536	123 355	133 382	125 320	113 088	110 821	116 373	92 660
Long-Term Debt	1 259	1 744	8 443	12 095	7 731	9 407	7 952	15 632	33 971	30 140	21 325	20 350	102	1 922	620	186	3 093	9 473	24 814	7 702	5 956	7 304	13 044	35 329
Deferred Income Tax	0	0	0	0	0	173	75	2 760	2 871	3 568	3 808	2 972	2 567	2 223	5 288	4 304	3 209	1 953	3 706	3 706	3 706	3 521	3 521	6 436
Minority Interest	0	0	0	0	0	0	0	0	5 255	5 829	5 483	5 611	4 709	4 171	3 923	3 685	4 011	3 384	3 686	3 574	5 617	5 745	5 302	6 271
Other Liabilities	1 019	1 221	1 493	2 008	2 191	2 298	2 567	3 887	3 741	4 260	3 817	4 512	5 065	6 206	9 283	11 399	12 520	15 221	22 344	15 522	14 640	13 537	14 856	20 441
Total Liabilities	10 321 N/A	11 871 +15%	14 222 +20%	18 873 +33%	24 135 +28%	26 153 +8%	33 621 +29%	41 533 +24%	95 277 +129%	130 658 +37%	124 855 -4%	121 080 -3%	123 922 +2%	121 679 -2%	136 221 +12%	130 081 -5%	137 369 +6%	153 386 +12%	187 932 +23%	155 824 -17%	143 006 -8%	140 928 -1%	153 096 +9%	161 137 +5%
Equity
Common Stock	3 528	3 528	3 528	3 528	3 528	3 528	3 830	5 100	5 294	5 500	8 166	8 500	8 500	8 755	9 055	11 610	12 020	12 270	12 270	16 977	16 977	16 977	16 977	16 977
Retained Earnings	1 724	1 136	1 392	4 599	8 278	13 383	19 966	24 830	27 093	46 551	38 507	25 826	26 992	38 803	8 101	13 656	20 001	15 142	8 271	33 723	39 976	11 425	6 031	564
Additional Paid In Capital	437	437	437	437	437	437	1 947	16 212	28 154	16 770	21 410	21 372	21 438	21 432	21 150	40 853	40 849	40 575	43 224	74 662	74 804	32 668	32 668	32 668
Unrealized Security Profit/Loss	0	0	0	0	0	0	5	11 579	31	0	11 562	11 562	11 562	0	24 906	24 906	24 906	21 801	29 394	29 394	28 560	28 560	28 560	47 681
Treasury Stock	0	0	0	0	0	0	0	1 797	1 985	1 988	1 996	435	435	440	448	463	500	540	540	540	540	540	1 215	1 471
Other Equity	0	0	0	0	0	0	0	0	14	0	0	432	432	432	432	432	432	432	432	432	432	432	432	432
Total Equity	2 241 N/A	2 830 +26%	5 357 +89%	8 565 +60%	12 243 +43%	17 349 +42%	25 749 +48%	55 924 +117%	58 573 +5%	66 832 +14%	77 649 +16%	67 257 -13%	68 489 +2%	68 982 +1%	63 197 -8%	90 995 +44%	97 708 +7%	89 680 -8%	76 510 -15%	87 201 +14%	80 257 -8%	89 522 +12%	83 453 -7%	96 851 +16%
Total Liabilities & Equity	12 562 N/A	14 701 +17%	19 579 +33%	27 438 +40%	36 378 +33%	43 502 +20%	59 369 +36%	97 457 +64%	153 850 +58%	197 490 +28%	202 504 +3%	188 337 -7%	192 410 +2%	190 661 -1%	199 417 +5%	221 075 +11%	235 077 +6%	243 066 +3%	264 442 +9%	243 025 -8%	223 263 -8%	230 450 +3%	236 549 +3%	257 988 +9%
Shares Outstanding
Common Shares Outstanding	12	12	12	12	12	12	13	16	17	17	20	21	20	21	21	25	25	25	25	34	34	34	34	33

Income Statement Balance Sheet Cash Flow Statement

Myungmoon Pharm Co Ltd
KRX:017180

Balance Sheet

Balance Sheet Decomposition
Myungmoon Pharm Co Ltd

Balance Sheet
Myungmoon Pharm Co Ltd

See Also

Company

Help

Tools

Stocks

Myungmoon Pharm Co Ltd KRX:017180

Balance Sheet

Balance Sheet Decomposition Myungmoon Pharm Co Ltd

Balance Sheet Myungmoon Pharm Co Ltd

See Also

Company

Help

Tools

Stocks

Myungmoon Pharm Co Ltd
KRX:017180

Balance Sheet Decomposition
Myungmoon Pharm Co Ltd

Balance Sheet
Myungmoon Pharm Co Ltd